APO-Metformin (2020-02-04)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
APO-Metformin 500 mg Tablet
| Lot or serial number | Companies | Brand name | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| NV3242, NV3244, NV3245, NV3243, NV3247, NV3248, PX5334, PX5335 | - Recalling Firm
- Apotex Inc.
- 150 Signet Drive
- Toronto
- M9L 1T9
- Ontario
- CANADA
- Marketing Authorization Holder
- Apotex Inc.
- 150 Signet Drive
- Toronto
- M9L 1T9
- Ontario
- CANADA
| APO-Metformin 500 mg Tablet | DIN 02305062 | Tablet (Extended-Release) | Metformin Chlorohydrate 500 mg |
Presence of N-nitrosodimethylamine (NDMA) above the interim acceptable concentration limit in affected lot(s).
Wholesalers, Healthcare Establishments, Retailers